Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Qualified Opinion who wrote (20692)	7/30/2006 10:57:49 PM
From: Arthur Radley	Read Replies (3) \| Respond to of 52153

Rob...you say Pfizer "expects" to generate around $16 billion in operating cash flow. However "expects" and reality often come to a fork in the road and "expects" takes the left road and reality takes the right road. I'm of the old school of thought and that is once I buy shares in a company I don't want to play a game of horseshoes and merely get "leaners"...I want to score the big points with "ringers". Thus IMO the only thing that really counts in scoring is the actual stock price after you buy...and if you had bought PFE shares when McKinnell became the CEO in January, 2001 you would have lost over 40% by holding this stock. So my point is very simple...what did McKinnell do to earn a $83M severance package other than being arrogant and having a Napoleonic complex other than being over six feet tall.